Your browser doesn't support javascript.
loading
Comprehensive pharmacogenomic characterization of gastric cancer.
Sa, Jason K; Hong, Jung Yong; Lee, In-Kyoung; Kim, Ju-Sun; Sim, Moon-Hee; Kim, Ha Jung; An, Ji Yeong; Sohn, Tae Sung; Lee, Joon Ho; Bae, Jae Moon; Kim, Sung; Kim, Kyoung-Mee; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Lim, Ho Yeong; Kang, Won Ki; Her, Nam-Gu; Lee, Yeri; Cho, Hee Jin; Shin, Yong Jae; Kim, Misuk; Koo, Harim; Kim, Mirinae; Seo, Yun Jee; Kim, Ja Yeon; Choi, Min-Gew; Nam, Do-Hyun; Lee, Jeeyun.
Afiliación
  • Sa JK; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.
  • Hong JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee IK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Sim MH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim HJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • An JY; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Sohn TS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee JH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Bae JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim KM; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park JO; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lim HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Her NG; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Lee Y; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Cho HJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Shin YJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim M; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Koo H; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim M; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Seo YJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim JY; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Choi MG; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Nam DH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. mingew.choi@samsung.com.
  • Lee J; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea. nsnam@skku.edu.
Genome Med ; 12(1): 17, 2020 02 18.
Article en En | MEDLINE | ID: mdl-32070411
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Resistencia a Antineoplásicos / Variantes Farmacogenómicas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Resistencia a Antineoplásicos / Variantes Farmacogenómicas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2020 Tipo del documento: Article